By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioMarin Pharmaceutical Inc. 

105 Digital Drive

Novato  California  94949  U.S.A.
Phone: 415-506-6700 Fax: 415-382-7427



Company News
Medivation (MDVN) To Expand Global Oncology Franchise With The Acquisition Of All Worldwide Rights To Talazoparib (BMN 673), A Potent PARP Inhibitor, From BioMarin (BMRN) 8/24/2015 10:07:35 AM
BioMarin (BMRN) Sells Phase III Breast Cancer Drug to Medivation (MDVN) for $570 Million 8/24/2015 6:17:15 AM
BioMarin (BMRN) Receives Rare Pediatric Disease Designation From FDA For Drisapersen For The Potential Treatment Of Duchenne Muscular Dystrophy 8/20/2015 7:55:58 AM
Forbes Ranks BioMarin (BMRN) 10th Most Innovative Company In The World 8/19/2015 10:40:22 AM
BioMarin (BMRN) Announces Second Quarter 2015 Financial Results And Company Update 8/4/2015 8:00:06 AM
BioMarin (BMRN) Joins The NASDAQ-100 Index 7/27/2015 7:47:41 AM
Investors Gear Up For Exciting News as FDA Sets Dates for BioMarin (BMRN) and Sarepta (SRPT) DMD Drugs 7/21/2015 6:34:03 AM
BioMarin (BMRN) Provides Program Update For Talazoparib In Metastatic Breast Cancer 7/20/2015 6:59:18 AM
BioMarin (BMRN) To Host Second Quarter 2015 Financial Results Conference Call And Webcast On Monday, August 3 At 4:30pm ET 7/15/2015 7:20:09 AM
Sarepta (SRPT) and BioMarin (BMRN) Rivalry Heats Up as Sarepta Shops for Second DMD Drug 7/14/2015 6:01:16 AM